Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Electrophysiological assays using oocytes that express human ENaC and the use of phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes

Electrophysiological assays using oocytes that express human ENaC and the use of phenamil to improve the effect of ENaC enhancers in assays using membrane potential reporting dyes

US Patent 10048274 · Granted Aug 14, 2018

Estimated economic value: $913,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antagonists of T2R54 and compositions and uses thereof2025
5-substituted 4-amino-1H-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulation2024
Antagonists of T2R54 and compositions and uses thereof2024
Substituted 4-amino-5-(cyclohexyloxy)quinoline-3-carboxylic acids as sweet flavo2022
Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, a2022
Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, a2020
Plasma generating apparatus and substrate processing apparatus2020
Screening assays to identify compounds which modulate T1R associated taste modal2019
Electrophysiological assays using oocytes that express human ENaC and the use of2019
Electrophysiological assays using oocytes that express human ENaC and the use of2019
Electrophysiological assays using oocytes that express human ENaC and the use of2019
Electrophysiological assays using oocytes that express human ENaC and the use of2019